Public trial registry of the CCC-Munich

Trial A5481003 / TRIO-018

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
A5481003 / TRIO-018
World
Full title
:

PHASE 1/2, OPEN-LABEL, RANDOMIZED STUDY OF THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF LETROZOLE PLUS PD 0332991 (ORAL CDK 4/6 INHIBITOR) AND LETROZOLE SINGLE AGENT FOR THE FIRST-LINE TREATMENT OF ER POSITIVE, HER2 NEGATIVE ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN

World
Responsible organization
:
Frauenklinik Frauenklinik Ismaninger Str. 22 81675 M√ľnchen Germany Tum
Indications
Classification Code Description
- C50.0 Mammakarzinom
Trial design
World
Phase
:
I/II
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Positive
World
Institutional review board - vote date
:
2009-07-08
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo

Participants
Function Prename Surname Organization
World Responsible contact Johannes Ettl Keine Organisationseinheit angegeben Magnifier